2005
DOI: 10.1021/ar040223k
|View full text |Cite
|
Sign up to set email alerts
|

Multivalency and Cooperativity in Supramolecular Chemistry

Abstract: Multivalent interactions, which rely upon noncovalent bonds, are essential ingredients in the mediation of biological processes, as well as in the construction of complex (super)structures for materials applications. A fundamental understanding of multivalency in supramolecular chemistry is necessary not only to construct motors and devices on the nanoscale but also to synthesize model systems to provide insight into how biological processes work. This Account focuses on the application of multivalency to supr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
373
0
10

Year Published

2005
2005
2013
2013

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 624 publications
(399 citation statements)
references
References 60 publications
3
373
0
10
Order By: Relevance
“…Liposomes, polymers, dendrimers, nanoparticles, and even proteins and viruses have all been utilized for ligand presentation (Badjic et al, 2005;Kane, 2006;Kiessling et al, 2006;Lewis et al, 2006;Mammen et al, 1998). The engineering of novel polyvalent scaffolds remains an attractive area for future research.…”
Section: Choosing a Scaffoldmentioning
confidence: 99%
See 1 more Smart Citation
“…Liposomes, polymers, dendrimers, nanoparticles, and even proteins and viruses have all been utilized for ligand presentation (Badjic et al, 2005;Kane, 2006;Kiessling et al, 2006;Lewis et al, 2006;Mammen et al, 1998). The engineering of novel polyvalent scaffolds remains an attractive area for future research.…”
Section: Choosing a Scaffoldmentioning
confidence: 99%
“…In recent years, there has also been a tremendous interest in the design of novel polyvalent molecules (Badjic et al, 2005;Kane, 2006;Kiessling et al, 2006;Krishnamurthy et al, 2006;Mammen et al, 1998;Mulder et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…
The design of polyvalent molecules [1][2][3][4][5], consisting of multiple copies of a ligand attached to a suitable scaffold, represents a promising approach for designing potent inhibitors of pathogens and microbial toxins [1,[6][7][8][9][10][11]. Liposomes are particularly attractive scaffolds for designing polyvalent inhibitors [9,10,[12][13][14][15]; however, the poor colloidal stability of conventional liposomes and their short circulation times in vivo [16,17] are major obstacles limiting their therapeutic use.
…”
mentioning
confidence: 99%
“…Lett. 2002, 4, 679-682) in a template-directed synthesis of a precursor bis [2]rotaxane that requires that a bisdibenzo [24]crown-8 core is threaded with a bis-(bromomethyl)-substituted dibenzylammonium ion derivative before stoppering is achieved with an excess of Ph 3P. The best yield obtained in this sequence of reactions was 37% overall, a major byproduct being the intermediate mono [2]rotaxane isolated in 28% yield.…”
Section: O M M U N I C a T I O N Smentioning
confidence: 99%
“…2002, 4, 679-682) in a template-directed synthesis of a precursor bis [2]rotaxane that requires that a bisdibenzo [24]crown-8 core is threaded with a bis-(bromomethyl)-substituted dibenzylammonium ion derivative before stoppering is achieved with an excess of Ph 3P. The best yield obtained in this sequence of reactions was 37% overall, a major byproduct being the intermediate mono [2]rotaxane isolated in 28% yield. Subsequent treatment of the bis [2]rotaxane with Fréchet-type wedge-shaped aldehydes (G1 and G2) effected Wittig reactions affording isomeric mixtures of tetraolefins, which were hydrogenated catalytically.…”
Section: O M M U N I C a T I O N Smentioning
confidence: 99%